Skip to content

5-MeO-DMT: all studies

Page 108 of 110: studies 1,071 to 1,080 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

A characteristic effect of hallucinogens on investigatory responding in rats.

Psychopharmacology September 1979 Mark A. Geyer, Roger K. Light, Gary J. Rose et al.

The disruption of the temporal distribution of investigatory responses by rats in a novel hole-board following lysergic acid diethylamide-25 (LSD), as described in a companion paper (Geyer and Light, 1979), was found to be a characteristic effect of a variety of hallucinogens. Similar effects were produced by indoleamine hallucinogens, such as LSD, N,N-dimethyltryptamine, and psilocin, and by...

Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.

Psychopharmacology April 25, 1979 D Ruffing, B Kovacic, S Demetriou et al.

The narcotic antagonist naloxone was tested to determine its possible interaction with N,N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) in adult male Holtzman rats trained to press a bar on a fixed-ratio four schedule (FR4), i.e., every fourth press earned a reward of 0.01 ml sugar sweetened milk. LSD (0.1 mg/kg) or increasing doses of DMT (1.0, 3.2, and 10.0 mg/kg) were...

Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat

Psychopharmacology 1979 R. Malcolm Stewart, Alexander Campbell, Günther Sperk et al. 43 citations

Muscle twitches and autonomic changes were induced by systemic injections of L -5-hydroxytryptophan (5-HTP) or the serotonin agonist 5-methoxy- N,N -dimethyltryptamine (5-MeO-DMT) in rats previously lesioned with intracranial 5,7-dihydroxytryptamine (5,7-DHT) after desmethylimipramine. Movements were recorded sensitively and continuously by an electronic activity monitor. Spontaneous locomotor...

DOI: 10.1007/bf00426669 (opens in new tab) Full text (opens in new tab) Serotonin Denervation Dihydroxytryptamines Muscle spasms +2

The intracranial injection of drugs in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity

Journal of Asthma Research 1979 Harold A. Abramson, H. H. Gettner, P. A. Carone et al. 4 citations

A simplified method of studying the surfacing reaction of goldfish to hallucinogens is described. Goldfish weighing up to three grams are injected intracranially. Employing this method, d-lysergic acid diethylamide (LSD-25), d-2-acetyl lysergic acid diethylamide (ALD-52), 1-methyl d-lysergic acid butano-lamide (UML-491), and 5-methoxy dimethyl tryptamine (5-MEO-DMT) were found to be as...

The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.

Journal of Pharmacology and Experimental Therapeutics December 1, 1978 Mark A. Geyer, Lyle R. Petersen, Gary J. Rose et al. 69 citations

Tactile startle responding by male Sprague-Dawley rats given 60 presentations of air-puff stimuli (37.5 psi) was measured after the intraperitoneal administration of graded doses of hallucinogens and other psychoactive drugs. Among the drugs tested were the indoleamine-derived compounds, lysergic acid diethylamide (LSD), N,N-dimethyltryptamine and psilocin, and the phenylethylamine-derived...

Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.

Psychopharmacology April 11, 1978 Herbert Y. Meltzer, Richard G. Fessler, Miljana Simonovic et al. 24 citations

The hallucinogenic indoleamine drugs N,N-dimethyltryptamine (N,N-DMT), psilocybin, bufotenin, 5-methoxy-N,N-dimethyltryptamine, and N-methyltryptamine, increased rat plasma prolactin (PRL) levels. The increase in plasma PRL produced by N,N-DMT, psilocybin, and bufotenin was inhibited by methysergide, a serotonin receptor blocker. Parachlorophenylalanine (PCPA), an inhibitor of serotonin...

The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine

American Journal of Psychiatry February 1, 1976 123 citations

The authors review the research on N,N-dimethyltryptamine (DMT) as a possible "schizotoxin." DMT produces psychedelic effects when administered to normal subjects, the means are present to synthesize it in man, it has occasionally been found in man, and tolerance to its behavioral effects is incomplete. However, DMT concentrations have not been proven to differ significantly in schizophrenics...

Dimethyltryptamine levels in blood of schizophrenic patients and control subjects

Psychopharmacology 1976 B. Angrist, S. Gershon, G. Sathananthan et al. 44 citations

A gas chromatographic-mass spectrometric determination of blood N,N-dimethyltryptamine in normal controls and schizophrenic patients was carried out with a sensitivity limit of 0.05 ng/ml whole blood. Although the results appear to suggest that the mean DMT level was higher in the total patient group, those patients with acute psychosis, female patients and patients with suspiciousness scores...

A test of the transmethylation hypothesis in acute schizophrenic patients.

American Journal of Psychiatry October 1, 1975 W T Carpenter, E B Fink, N Narasimhachari et al. 31 citations

Keeping biochemical determinations and clinical judgements independent, the authors investigated three aspects of the transmethylation hypothesis. They found that 26 acutely schizophrenic patients were no more likely to have bufotenine or N,N-dimethyltryptamine present in urine or elevated serum indolethylamine N-methyltransferase activity than 10 normal control subjects. The authors conclude...